Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients
- Conditions
- Advanced Gastrointestinal Cancer
- Interventions
- Behavioral: single pilot interviewBehavioral: usual careBehavioral: goals-of-care (GOC) videoBehavioral: goals-of-care (GOC) video and narrative questionBehavioral: Part 2
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 178
- Registration Number
- NCT01912131
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
- Conditions
- T Cell Non-Hodgkin Lymphoma
- Interventions
- Other: High Dose Chemotherapy with Autologous Stem Cell Transplant Followed by Maintenance Therapy with Romidepsin
- First Posted Date
- 2013-07-26
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 47
- Registration Number
- NCT01908777
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Radiation: Stereotactic Body Radiation Therapy (SBRT)
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 39
- Registration Number
- NCT01899989
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT01894672
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
- Conditions
- Brain Cancer
- Interventions
- Device: Optune (NovoTTF-100A)
- First Posted Date
- 2013-07-04
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT01892397
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
- Conditions
- Renal Cancer
- Interventions
- Behavioral: (EORTC QLQ-C30) questionnaireBehavioral: EuroQol EQ-5D 7-item questionnaire
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 294
- Registration Number
- NCT01888198
- Locations
- 🇺🇸
Md Anderson Cancer Center, Houston, Texas, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
🇺🇸University of Maryland Medical Center, Baltimore, Maryland, United States
Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
- Conditions
- Thyroid Cancer
- Interventions
- Radiation: IMRTDevice: DWI MRIOther: Modified Barium Swallow Impairment Profile (MBSImP)
- First Posted Date
- 2013-06-20
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT01882816
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
- Conditions
- Low Risk Prostate Cancer
- Interventions
- Behavioral: assessments
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 541
- Registration Number
- NCT01877070
- Locations
- 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Mount Sinai Hospital, New York, New York, United States
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
- Conditions
- Germ Cell Tumors
- Interventions
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 92
- Registration Number
- NCT01873326
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins
- Conditions
- Basal Cell CarcinomaSquamous Cell Carcinoma
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2020-05-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT01872130
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center Hauppauge, Hauppauge, New York, United States